SYDNEY CIRA: Open Payments
NPI 1063124352 · EUCLID, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$796 in 30 payments from 13 companies in 2025. Trend: 2023 $583 · 2024 $884 · 2025 $796
Food & beverage: $796
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 6 | $131 |
| Corcept Therapeutics | 4 | $109 |
| Ascendis Pharma Endocrinology Inc | 1 | $107 |
| Madrigal Pharmaceuticals | 3 | $89 |
| Neurocrine BioSciences, Inc. | 3 | $64 |
| RECORDATI_RARE_DISEASES_INC. | 3 | $62 |
| Xeris Pharmaceuticals, Inc. | 3 | $59 |
| Dexcom, Inc. | 2 | $54 |
| Alexion Pharmaceuticals, Inc. | 1 | $30 |
| Sequel Med Tech, LLC | 1 | $28 |
Products named: MOUNJARO, Korlym, Yorvipath, REZDIFFRA, CRENESSITY, ISTURISA, Dexcom G6 Transmitter, RECORLEV.
Industry payments across OH — which companies pay providers there.
